tiprankstipranks
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market

Edgewise Therapeutics (EWTX) Income Statement

Compare
294 Followers

Edgewise Therapeutics Income Statement

Last quarter (Q3 2024), Edgewise Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Edgewise Therapeutics's net income was $-34.13M. See Edgewise Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.73M$ -538.00K$ -272.00K$ -185.00K$ -123.00K
Operating Expenses
$ 114.36M$ 22.08M$ 43.22M$ 17.19M$ 9.92M
Depreciation and Amortization
$ 1.73M$ 538.00K$ 272.00K$ 185.00K$ 123.00K
EBITDA
$ -112.81M$ -67.10M$ -42.94M$ -17.01M$ -9.80M
Operating Income
$ -114.36M$ -22.08M$ -43.22M$ -17.19M$ -9.92M
Other Income/Expenses
$ 14.19M$ 4.02M$ 402.00K$ 69.00K$ 219.00K
Pretax Income
$ -100.16M$ -19.41M$ -42.81M$ -17.12M$ -9.71M
Net Income
$ -100.16M$ -15.40M$ -42.14M$ -17.05M$ -9.49M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.57$ -0.29$ -0.85$ -0.35$ -0.19
Diluted EPS
$ -1.57$ -0.29$ -0.85$ -0.35$ -0.19
Weighted Average Shares Outstanding
63.72M 53.59M 49.50M 49.22M 49.22M
Weighted Average Shares Outstanding (Diluted)
63.72M 53.59M 49.50M 49.22M 49.22M
Currency in USD

Edgewise Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis